ICON Public (NASDAQ:ICLR) Updates FY 2025 Earnings Guidance

ICON Public (NASDAQ:ICLR) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 13.000-15.000 for the period, compared to the consensus earnings per share estimate of 14.930. The company issued revenue guidance of $8.1 billion-$8.7 billion, compared to the consensus revenue estimate of $8.5 billion. ICON Public also updated its FY 2024 guidance to 13.900-14.100 EPS.

Analyst Upgrades and Downgrades

ICLR has been the subject of a number of research analyst reports. Truist Financial reiterated a “buy” rating and issued a $284.00 price target (down previously from $295.00) on shares of ICON Public in a report on Wednesday, December 18th. Barclays dropped their price target on ICON Public from $330.00 to $275.00 and set an “overweight” rating for the company in a research report on Friday, October 25th. TD Cowen dropped their target price on shares of ICON Public from $369.00 to $285.00 and set a “buy” rating for the company in a report on Friday, October 25th. Robert W. Baird reduced their price target on shares of ICON Public from $249.00 to $225.00 and set a “neutral” rating on the stock in a report on Wednesday, November 20th. Finally, StockNews.com cut shares of ICON Public from a “buy” rating to a “hold” rating in a research note on Thursday, September 19th. Four research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $287.00.

ICON Public Stock Performance

ICON Public stock opened at $217.99 on Tuesday. The stock has a fifty day moving average price of $211.31 and a 200 day moving average price of $270.81. The company has a current ratio of 1.34, a quick ratio of 1.34 and a debt-to-equity ratio of 0.35. ICON Public has a 52 week low of $183.38 and a 52 week high of $347.72. The firm has a market capitalization of $17.98 billion, a P/E ratio of 24.30, a PEG ratio of 1.54 and a beta of 1.20.

ICON Public (NASDAQ:ICLR) last announced its quarterly earnings data on Wednesday, October 23rd. The medical research company reported $3.35 earnings per share for the quarter, missing the consensus estimate of $3.72 by ($0.37). ICON Public had a return on equity of 11.91% and a net margin of 9.00%. The company had revenue of $2.03 billion for the quarter, compared to analysts’ expectations of $2.13 billion. During the same quarter in the previous year, the company earned $3.10 earnings per share. The company’s revenue was down 1.2% on a year-over-year basis. Equities research analysts anticipate that ICON Public will post 13.42 earnings per share for the current year.

ICON Public Company Profile

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.